OBI Pharma Inc

Common Name
OBI Pharma
Country
Taiwan
Sector
Healthcare
Industry
Biotechnology
Employees
N/A
Ticker
4174
Exchange
TAIPEI EXCHANGE
Description
OBI Pharma, Inc., a clinical stage oncology company, research and develops novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. The company's pipeline product...

OBI Pharma's GHG Emissions Data Preview

In 2022, OBI Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

However, OBI Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into OBI Pharma's Operational Emissions

In 2022, the total operational greenhouse gas (GHG) emissions of OBI Pharma amounted to 577.641 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).

OBI Pharma's Scope 1 Emissions Over Time

202207142128tCO2e
  • Total Scope 1
  • Year-over-Year Change

What are OBI Pharma's Scope 1 emissions?

In 2022, the total Scope 1 emissions of OBI Pharma were 25.331 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).

What are OBI Pharma's Scope 2 emissions?

In 2022, OBI Pharma reported Scope 2 greenhouse gas (GHG) emissions of 552.311 tCOâ‚‚e without specifying the calculation method.

What methodology does OBI Pharma use for Scope 2 reporting?

In 2022, OBI Pharma reported its Scope 2 emissions using an unspecified methodology.

OBI Pharma's Scope 2 Emissions Over Time

20220150300450600tCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into OBI Pharma's Value Chain Emissions

In 2022, OBI Pharma reported 168.562 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.

The 2022 disclosure of OBI Pharma includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in , demonstrating consistent Scope 3 emissions reporting coverage year over year.

OBI Pharma's Scope 3 Emissions Over Time

202204590135180tCO2e
  • Total Scope 3
  • Year-over-Year Change

What are OBI Pharma's Scope 3 emissions?

In 2022, OBI Pharma reported total Scope 3 emissions of 168.562 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).

Insights into OBI Pharma's Total Carbon Footprint

In 2022, OBI Pharma reported a total carbon footprint of 746.203 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions.

The largest contributor to OBI Pharma's total carbon footprint was Scope 2 emissions, accounting for 74.02% of the company's total carbon footprint, followed by Scope 3 emissions at 22.59%.

Want Full Access to OBI Pharma's GHG Emissions Dataset?
Sign Up